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Abstract: Periodontitis is a major cause for tooth loss, which affects about 15% of the adult 
population. Cementum regeneration has been the crux of constructing the periodontal complex. 
Cementum protein 1 (CEMP1) is a cementum-specific protein that can induce cementogenic 
differentiation. In this study, poly(ethylene glycol) (PEG)-stabilized amorphous calcium 
phosphate (ACP) nanoparticles were prepared by wet-chemical method and then loaded with 
recombinant human CEMP1 (rhCEMP1) for controlled release. An electrospun multiphasic 
scaffold constituted of poly(ε-caprolactone) (PCL), type I collagen (COL), and rhCEMP1/ACP 
was fabricated. The effects of rhCEMP1/ACP/PCL/COL scaffold on the attachment proliferation, 
osteogenic, and cementogenic differentiations of human periodontal ligament cells, (PDLCs) 
were systematically investigated. A critical size defect rat model was introduced to evaluate the 
effect of tissue regeneration of the scaffolds in vivo. The results showed that PEG-stabilized 
ACP nanoparticles formed a core-shell structure with sustained release of rhCEMP1 for up to 
4 weeks. rhCEMP1/ACP/PCL/COL scaffold could suppress PDLCs proliferation behavior and 
upregulate the expression of cementoblastic markers including CEMP1 and cementum attach-
ment protein while downregulating osteoblastic markers including osteocalcin and osteopontin 
when it was cocultured with PDLCs in vitro for 7 days. Histology analysis of cementum after 
being implanted with the scaffold in rats for 8 weeks showed that there was cementum-like tissue 
formation but little bone formation. These results indicated the potential of using electrospun 
multiphasic scaffolds for controlled release of rhCEMP1 for promoting cementum regeneration 
in reconstruction of the periodontal complex.
Keywords: nanofiber scaffold, rhCEMP1, controlled release, cementum regeneration, in vivo
Background
Periodontitis is a common oral inflammatory disease induced by periodontal pathogens 
that causes periodontal tissue destruction, including connective attachment loss and 
alveolar bone resorption, thereby resulting in tooth loss.1 To date, periodontal recon-
struction based on infection control is still the key solution for periodontal treatment. 
However, the bottle neck for periodontal reconstruction is that it is difficult to regenerate 
cementum. Cementum represents a unique avascular-mineralized connective tissue that 
covers the root surface of the teeth. It provides the interface through which Sharpey’s 
collagen fibers of the periodontal ligament are anchored to the root surface. A number 
of studies show that cementum protein 1 (CEMP1, one kind of growth factor [GF]) 
promotes cell attachment, differentiation, extracellular matrix (ECM) deposition, and 
affects the composition, and morphology of hydroxyapatite (HA) crystals formed by 
human cementoblast cells in vitro.1–5 These observations confirm that CEMP1 plays 
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an important role during the cementum formation and the 
biomineralization process.
However, there is lack of experimental data to ascertain 
the ability of recombinant human CEMP1 (rhCEMP1) to 
induce cementum regeneration in vivo. Although CEMP1 
is beneficial for cementum regeneration, direct application 
of CEMP1 in tissue engineering is restricted due to its short 
biological half-life, systemic side effects, and rapid clear-
ance. Given the obstacles surrounding the issue, we induced 
a sustained releasing system to fit with the tardy regeneration 
process of cementum.
Recently, biodegradable scaffolds have been designed 
and successfully used in the repair and regeneration of 
damaged or diseased tissues. In addition, GFs can be encap-
sulated within these scaffolds to circumvent the premature 
release and the degradation of the GF before it reaches the 
targeting site. GFs encapsulated inside these scaffolds can 
be released according to cellular demands in a controlled 
manner,6 allowing similar reparative processes to be induced 
by low GF concentration.7 Importantly, controlled release of 
vascular endothelial growth factor from the scaffold leads to 
the formation of a more organized vasculature in comparison 
to the vasculature that arises from the uncontrolled vascular 
endothelial growth factor release.8 Furthermore, multiple GFs 
can be incorporated in one scaffold, which may complement 
one another temporally and spatially.9,10 However, scaffolds 
fabricated with a sole component usually exhibit limited 
mechanical properties and fail to mimic the natural tissue. To 
address this shortcoming, biomimetic hybrid scaffolds com-
posed of polymer and calcium phosphate nanoparticles were 
developed to successfully regenerate human tooth–ligament 
interfaces.11 The calcium phosphate not only enhanced the 
toughness of the scaffold, but also improved its biocompat-
ibility and accelerated the biomineralization procedure, 
because the chemical composition of calcium phosphate is 
similar to the inorganic phase of bone. Therefore, CEMP1-
encapsulated scaffolds seem to be suitable in the cementum 
formation and the biomineralization process, which not only 
acts as a physical and biological support for cementum regen-
eration, but also a three-dimensional (3D) artificial cementum 
ECM to mimic the structure and function of cementum.
Inspired by the merits of the hybrid scaffold, in this work, 
a robust CEMP1-encapsulated hybrid scaffold composed 
of poly(ε-caprolactone) (PCL), Type I collagen (COL), and 
poly(ethylene glycol) (PEG)-modified amorphous calcium 
phosphate (ACP) [Ca
3
(PO
4
)
2
⋅3H
2
O] was designed and 
fabricated through electrospinning method. PCL possesses 
remarkable toughness and good biocompatibility in addition 
to a high elongation and fracture energy.12–14 Its flexibility 
has been used to overcome the brittleness and low elon-
gation property of pure inorganic scaffolds.15 COL and 
calcium phosphate are the main constituents of cementum 
ECM.16 The presence of COL in the scaffold is conducive 
to tissue regeneration, including good biocompatibility, no 
immunogenicity, no toxicity, and supporting, protecting, 
and mediating cell adhesion.17 The use of ACP has some 
advantages: ACP shows better osteoconductive property 
than HA in vivo and its biodegradability is higher than that 
of tricalcium phosphate.18 Furthermore, the conversion of 
ACP to HA will release functional calcium and phosphate 
ions as convenient and fast sources of raw materials for the 
regeneration of mineralized tissue.19
To maintain the bioactivity of CEMP1 during the elec-
trospinning, rhCEMP1 was first encapsulated inside PEG-
modified ACP, due to the tight affinity between CEMP1 and 
calcium phosphate.20 The encapsulation of rhCEMP1 inside 
the PEG-modified ACP can protect rhCEMP1 from contacting 
the organic solvent during the electrospinning, thus avoiding 
unwanted protein denaturation. The release of rhCEMP1 from 
the rhCEMP1/ACP nanoparticles was studied. Then an elec-
trospun multiphasic scaffold composed of rhCEMP1/ACP, 
PCL, and COL was fabricated and cocultured with periodontal 
ligament cells (PDLCs) to assess the biocompatibility and 
inductivity. Finally, the in vivo assessment of tissue regenera-
tion was conducted in a critical size defect rat model.
Materials and methods
Materials and reagents
All reagents and chemicals were purchased from Aladdin 
(Shanghai, People’s Republic of China) unless otherwise 
stated. Plasmids and BL21 (DE3) were purchased from 
Thermo Fisher Scientific (Waltham, MA, USA). rhCEMP1 
enzyme-linked immunosorbent assay kit was purchased from 
CUSABIO (Wuhan, Hubei, People’s Republic of China). 
PCL was purchased from Dai Gang Biology (PCL, molecular 
weight of 160 kDa; Shanghai, People’s Republic of China). 
COL was purchased from Sigma-Aldrich (Wadena, MN, 
USA) and α-minimum essential medium (α-MEM) was from 
Hyclone (Logan, UT, USA). Fetal bovine serum and antibiot-
ics were purchased from Gibco (Grand Island, NY, USA).
synthesis and characterization of acPs 
and rhceMP1-loaded acPs (acPPs) 
nanoparticles
Briefly, CaCl
2
 and PEG (molecular weight: 10,000) with 
designed ratios of 1:1 (w/w) were dissolved in distilled water 
to form 0.1 M solution of CaCl
2
, which was immersed in 
an ice-water bath. Then Na
3
PO
4
⋅12H
2
O aqueous solution 
International Journal of Nanomedicine 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3147
controlled release of rhceMP1 for cementum regeneration
(0.133 M) was added into the CaCl
2
/PEG solution with a 
Ca/P mole ratio of 1.5, and the reaction was continued in 
ice water under 900 rpm stirring for 30 minutes. The ACP 
nanoparticles were obtained by washing the precipitates 
with distilled water repeatedly to remove the unwanted ions 
(Na+ and Cl-) and freeze-dried for 48 hours. The blank cal-
cium phosphate samples were prepared without the presence 
of PEG, as the control.
For the preparation of ACPPs, 5 mL distilled water was 
added to suspend the ACP precipitates. A specified amount 
of lyophilized rhCEMP1 (as listed in Table 1) powder was 
allowed to incorporate into the ACP precipitates by stirring 
at 900 rpm for 5 minutes in an ice-water bath to afford a 
mixture in which the net share of rhCEMP1 in dry state 
would be 1%, 2%, 5%, and 8% (w/w). The new precipitates 
containing rhCEMP1 were named ACPPs and freeze-dried 
for 48 hours.
Production of rhCEMP1 has been described in earlier 
studies.21 Briefly, rhCEMP1 complementary DNA (cDNA) 
was optimized and inserted into corresponding sites of inter-
mediate vector pENTR/SD/D after restriction endonuclease 
digestion, and then inserted into vector pET28a. The recom-
binant vector pET28a-rhCEMP1 was confirmed by agarose 
gel electrophoresis and DNA sequence analysis. The plasmid 
was introduced into BL21 (DE3) expression host Escherichia 
coli strain. The expression of rhCEMP1 was determined by 
sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
and enzyme-linked immunosorbent assay.
The precipitates obtained in the absence and presence 
of PEG or rhCEMP1 were characterized by transmission 
electron microscopy (JEM-200CX; JEOL, Tokyo, Japan). 
Fourier-transform infrared spectroscopy (NEXUS870; 
NICOLET, San Carlos, CA, USA) was conducted in the 
range of 400–4,000 cm-1.
Encapsulation efficiency and controlled 
release of rhceMP1 from acPPs
About 10 mg of the freeze-dried ACPPs were dispersed 
in 10 mL of phosphate-buffered saline (PBS) in a shaker 
incubator at 100 rpm and 37°C for 5 minutes. Afterwards, 
the solution was centrifuged and the concentration of 
rhCEMP1 in the supernatant was assessed using rhCEMP1 
enzyme-linked immunosorbent assay kit. The ratio of super-
natant to actual protein weight was defined as encapsulation 
efficiency (EE) of the nanoparticles. The EE of rhCEMP1 
was calculated as:
 EE (%) t f
t
=
C C
C
−
×100, (1)
where C
f
 is the weight of free rhCEMP1 in the supernatant 
and C
t
 is the actual protein weight.
About 10 mg ACPPs were immersed into 10 mL of PBS 
(pH 7.4), and the samples were placed in a shaker incuba-
tor at 100 rpm and 37°C. At predetermined intervals (1, 3, 
7, 14, 21, and 28 days), the medium was retrieved and an 
equal volume of fresh medium was replenished. The amounts 
of rhCEMP1 in the release medium were ascertained by 
rhCEMP1 enzyme-linked immunosorbent assay kit.
Fabrication of electrospun multiphasic 
scaffold
Two kinds of scaffold were prepared using the electrospinning 
technique and named as ACP/COL/PCL and ACP/rhCEMP1/
COL/PCL. A solution strategy was adopted in polymer blend-
ing, and the detailed compositions are listed in Table 2. COL 
and PCL (weight ratio =1/1) were dissolved in hexafluor-
oisopropanol to yield a 25 w/v% solution. ACP or rhCEMP/
ACP-containing scaffolds were generated by admixing ACP 
or rhCEMP/ACP (a dispersion of 20 w/v% in hexafluoroiso-
propanol) to the polymer blend solutions (ACPP1 was chosen 
for fabricating the scaffold and then named as rhCEMP/ACP 
afterwards). A defined amount of genipin (GP) was added 
to cross-link the collagen before electrospinning. GP is a 
natural cross-linking agent extracted from the gardenia plant, 
and is less cytotoxic than glutaraldehyde. GP can react with 
proteins and produce blue-colored fluorescent hydrogels, 
thereby enabling cross-linking.22 The solution was drawn 
into a 10 mL syringe attached with a tip-blunt capillary (inner 
diameter =0.34 mm). A needlelike flow of the solution from 
the capillary spinneret was fed by a syringe pump at a flow 
rate of 2.5 mL/h. A high-voltage power supply was used at 
17 kV. The distance between the tip-blunt capillary and the 
Table 1 The compositions of electrospinning solutions
Sample HFIP (mL) COL (mg) PCL (mg) ACP (mg) ACP/rhCEMP1 (mg) GP (mg)
acP/cOl/Pcl 10 900 900 600 0 12
acP/rhceMP1/cOl/Pcl 10 900 900 0 600 12
Abbreviations: ACP, amorphous calcium phosphate; COL, Type I collagen; GP, genipin; HFIP, hexafluoroisopropanol; PCL, poly(ε-caprolactone); rhceMP1, recombinant 
human cementum protein 1.
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cover slips or aluminum foil that were used as collectors was 
15 cm. The obtained electrospun fibers were dried and then 
stored in clean polythene bags for further use.23
culture and seeding of PDlcs
Human PDLCs were retrieved, using a method adopted from 
Tanaka et al,24 from sound premolars extracted for orthodon-
tic reasons from five individuals (16–18 years old, three 
males and two females). All procedures in the study in both 
in vitro cell culture and in vivo animal model followed the 
approved ethical guidelines set by the Ethics Committee of 
Nanjing Stomatological Hospital. Written informed consent 
was obtained from all five individuals and/or their parents/
guardians. Briefly, teeth were rinsed three times with PBS 
supplemented with antibiotics (streptomycin 100 μg/mL, 
penicillin 100 units/mL). Periodontal ligament tissue was 
scraped from the middle-third of root surface with a surgi-
cal scalpel and cultured in α-MEM supplemented with 10% 
fetal bovine serum and antibiotics (streptomycin 100 mg/mL, 
penicillin 100 units/mL) in an atmosphere of 95% air/5% CO
2
 
at 37°C with 100% humidity. Cells were cultured in vitro and 
the third passage was used for the experiments.
The scaffolds were cut into circular discs with diameters 
of 5 mm (for 96-well plate), 19 mm (for 12-well plate), and 
25 mm (for 6-well plate) and sterilized in 70% ethanol for 
40 minutes and then washed with the culture medium to 
remove the alcohol residue. The cells were seeded on the 
sterilized scaffolds with a density of 6×103 cells/cm2 and were 
incubated at 37°C for 4 hours to promote cell attachment/
adhesion. Then, 1 mL of culture medium was added into each 
well. The culture medium was changed every 2 days.
assessment of PDlcs attachment, 
proliferation, and viability on 3D scaffolds
The cell viability and proliferation on the scaffolds was 
assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide (MTT) assay. At predetermined time inter-
vals (1, 3, and 7 days), the scaffolds were washed with PBS to 
remove nonadherent cells, and 10% MTT solution in α-MEM 
was added, followed by incubation for 3 hours; afterwards, the 
formazan crystals were dissolved in dimethyl sulfoxide. The 
absorbance of the solutions at 490 nm was recorded.
Morphology of the cells on the scaffolds was observed 
by scanning electron microscopy (SEM). At day 1, 3, and 7, 
the cell-seeded scaffolds were washed with PBS and fixed in 
2.5% glutaraldehyde, followed by dehydration in incremental 
concentrations of ethanol (15%, 30%, 50%, 70%, 80%, 
90%, and 100%) for 10 minutes each. Then, the specimens 
were dried at room temperature and coated with gold to be 
observed using SEM (S-3400N II; Hitachi, Tokyo, Japan).
effect of multiphasic scaffolds on 
osteogenic and cementogenic 
differentiation of PDlcs
To investigate the effect of multiphasic scaffold on the 
osteogenic-related gene expression of osteocalcin (OCN), 
osteopontin (OPN), cementogenic-related gene expression of 
CEMP1, and cementum attachment protein (CAP), PDLCs 
were seeded on ACP/PCL/COL or rhCEMP1/ACP/PCL/
COL scaffolds (PDLCs without scaffold were used as the 
control) and cultured in osteogenic differentiation medium 
10% FBS α-MEM (Sigma-Aldrich) in the presence of 
osteogenic supplements, namely, ascorbic acid (50 μg/mL; 
Biosharp, Carlsbad, CA, USA), β-glycerolphosphate (10 mM; 
Biosharp), and dexamethasone (10-8 M; Biosharp) for up to 
7 days. Total RNA was isolated from the cultured scaffolds 
using RNAiso plus (Takara, Tokyo, Japan). RNA concentra-
tion and purity were determined using a Nanodrop ND 1000 
Spectrophotometer (NanoDrop Technologies, Wilmington, 
DE, USA). Total RNA was prepared from cells using the 
RNAeasy Mini Kit according to the manufacturer instructions 
(Qiagen, Venlo, the Netherlands). One microgram of total 
RNA was used for cDNA synthesis using a PrimeScript™ 
II 1st Strand cDNA Synthesis Kit for real-time polymerase 
chain reaction (RT-PCR; Takara). Quantitative RT-PCR was 
carried out using Universal SYBR Green Supermix (Bio-Rad, 
Table 2 The compositions of acPs
Sample CaCl2 (mg) Na3PO4⋅12H2O (mg) PEG (mg) diH2O-A (mL) diH2O-B (mL) rhCEMP1 (mg)
acP 367.5 842.6 0 50 0 0
acPP0 367.5 842.6 367.5 50 0 0
acPP1 367.5 842.6 367.5 50 5 3.4
acPP2 367.5 842.6 367.5 50 5 6.8
acPP5 367.5 842.6 367.5 50 5 17.0
acPP8 367.5 842.6 367.5 50 5 27.2
Abbreviations: acP, amorphous calcium phosphate; Peg, poly (ethylene glycol); acPP1, 1% (w/w) rhceMP1 in acP/Peg; acPP2, 2% (w/w) rhceMP1 in acP/Peg; 
acPP5, 5% (w/w) rhceMP1 in acP/Peg; acPP8, 8% (w/w) rhceMP1 in acP/Peg; di, deionized; rhceMP1, recombinant human cementum protein 1.
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Hercules, CA, USA). Primer sequences are listed in Table 3. 
Amplification conditions were 95°C for 10 minutes for dena-
turation, then 40 cycles of 95°C for 15 seconds, 60°C for 1 
minute, and 95°C for 15 seconds, followed by a melting curve 
from 58°C to 98°C. Reaction products were quantified using 
StepOne Software (Version 2.1). Expression level values 
were normalized to that of an internal control, β-actin.
Implantation in rat calvaria model
The rat calvarial defect is generally used to evaluate bone 
regeneration in an orthotopic model and to screen biomaterials 
or tissue engineering constructs before moving to larger ani-
mals for potential translation to human applications. All proce-
dures followed the approved ethical guidelines set by the Ethics 
Committee of Nanjing Stomatological Hospital. This size of 
defect was chosen because it is the “critical size”: a defect of 
this size does not heal by itself without intervention.25
Rats with calvarial defects were divided into three 
groups, ACP/COL/PCL, rhCEMP1/ACP/COL/PCL, and 
control, with each group having six rats. To achieve this, 27 
male Wistar rats aged 7–8 weeks weighing 240–290 g were 
obtained from Model Animal Research Center of Nanjing 
University. The rats were positioned in a stereotaxic frame 
and immobilized during surgery. The hair over the skull of 
the animals was shaved, a full-thickness skin incision was 
made along the midline from the nasofrontal to occipital 
region, then the subcutaneous tissue was dissected, and the 
underlying periosteum was sharply incised/elevated to obtain 
sufficient exposure to the calvarium. A saline-cooled stainless 
steel trephine (5 mm outer diameter) was used to remove a 
full-thickness of bone to create the critical bone defects on 
both left and right sides of dorsal calvarium. Substantial 
caution was taken to prevent damage to the underlying 
sagittal sinus and dura mater. Then the bone defects were 
repaired with a 5 mm diameter scaffold of either ACP/PCL/
COL or rhCEMP1/ACP/PCL/COL. In the control group, the 
defect was left empty without repair. The periosteum and the 
subcutaneous tissue were closed sequentially with absorbable 
sutures. The skin wound was closed with 4–0 silk sutures. 
The animals were kept on a surgical bed until they awoke 
and had free access to food and water thereafter.
After 4 and 8 weeks postimplantation, the animals were 
sacrificed by CO
2
 asphyxiation and the calvaria bone of the 
rat was harvested and fixed in 10% formalin for 48 hours. 
The fixed samples were washed with PBS and were pro-
cessed and analyzed histologically and by micro-computed 
tomography (CT).
Micro-cT
Micro-CT of all specimens was performed using an X-eye 
micro-CT scanner (SEC, Gyeonggi-do, Korea) that has a very 
high spatial resolution through 360° and is equipped with an 
X-ray charge-coupled device camera of 1.4 M. The maximum 
tube current was 0.2 mA, maximum tube voltage was 160 kV, 
and the focus size was 1 μm. For each sample, 70 V tube 
voltage and 70 A current were maintained in the X-ray tube. 
To scan the whole calvaria, 400 microtomographic slices of 
every sample were taken with a slice increment of 30 μm. 
The micro-CT slices were processed using 3Di-Cat thresh-
olding, then used to create 3D models for visualization and 
quantitative histomorphometric analysis.
histological staining
After fixation in 10% neutral buffered formalin, the samples 
were rinsed with PBS several times and decalcified in 0.5% 
formaldehyde containing 10% ethylene diamine tetraacetic 
acid, pH 7.4, at 37°C in an incubator shaker. Then, the 
samples were embedded in tissue embedder (KMA-0100-00; 
CellPath Ltd., Newtown, UK), and 5 μm thick sections were 
prepared. Sections were perpendicular to the sagittal suture to 
produce a plane of analysis through the center of the defect. 
Representative sections were stained with H&E (hematoxylin 
and eosin). Additionally, Masson’s trichrome was visualized 
using an optical microscope for cross-reference.
statistical analysis
All the experiments were repeated three times, with each 
treatment conducted in triplicate unless otherwise stated. Data 
are represented as averages ± standard deviation and analyzed 
statistically by one-way analysis of variance (ANOVA) and a 
post hoc Student’s t-test. The post hoc t-test was performed 
when the ANOVA test indicated significance at P,0.05.
Table 3 Primer pairs used in qrT-Pcr analysis
Gene Primers
OCN F: 5′-cacTccTcgcccTaTTggc-3′
r: 5′-cccTccTgcTTggacacaaag-3′
OPN F: 5′-cTccaTTgacTcgaacgacTc-3′
r: 5′-caggTcTgcgaaacTTcTTagaT-3′
CAP F: 5′-TccagacaTTTgccTTgcTT-3′
r: 5′-TTacagcaaTagaaaaacagcaTga-3′
CEMP1 F: 5′-ggcgaTgcTcaaccTcTaac-3′
r: 5′-gaTacccaccTcTgccTTga-3′
β-actin F: 5′-gaTgagaTTggcaTggcTTT-3′
r: 5′-caccTTcaccgTTccagTTT-3′
Abbreviations: CAP, cementum attachment protein; CEMP1, cementum protein 1; 
OCN, osteocalcin; OPN, osteopontin; qrT-Pcr, quantitative real-time polymerase 
chain reaction; F, forward primer; r, reverse primer.
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Results
characterization of acPs
ACP nanoparticles obtained without the presence of PEG 
have a needlelike shape as shown in Figure 1A, which 
suggests the transformation of ACP to apatite because of 
the quick hydrolysis of ACP during the initial synthesis 
procedure.21 After the addition of PEG, the as-prepared 
ACP nanoparticles were covered by PEG, which hampered 
their hydrolysis. Consequently, a core–shell structure was 
clearly observed in Figure 1B. The gray shell is the PEG 
layer and the core is made of ACP (Figure 1B inset). After 
the incorporation of rhCEMP1 into the ACP nanoparticles, 
irregular morphology was observed, confirming the success-
ful encapsulation of rhCEMP1 (Figure 1C).
Infrared spectroscopy was conducted to measure the 
chemical composition of these samples. Figure 2 shows the 
spectra of rhCEMP1, ACP, ACP/PEG, rhCEMP1/ACP/
PEG, and their characteristic peaks. The characteristic 
vibration peaks of tetrahedral PO
4
3− ions at 590–610 cm-1 
and around 1,000 cm-1 are clearly observed in the infrared 
spectrum of ACP (Figure 2).26 The large and strong bands 
at 2,886 cm-1 were attributed to CH
2
 stretch in the spectrum 
of ACP/PEG, and the shoulder at 842 cm-1 was attributed 
to C–O stretch,27 confirming the presence of PEG. The 
characteristic peaks of amide I and amide II of rhCEMP1 
at 1,653 and 1,547 cm-1,28 as well as the bending vibration 
of PEG near 842 cm-1 were all observed in rhCEMP1/ACP/
PEG. These results further confirmed the encapsulation of 
rhCEMP1 inside the ACPPs.
ee and controlled release of rhceMP1 
from acPPs
The loading ratios and EEs were measured, and the results 
are shown in Figure 3A. When these ACP/PEG nanopar-
ticles were immersed in the rhCEMP1 solution at differ-
ent concentrations (1%, 2%, 5%, and 8% [w/w]), the EE 
of rhCEMP1 inside ACP/PEG was 97.8±2.2, 96.4±1.2, 
81.3±3.6, and 81.3±3.6, respectively.
Cumulative release profiles of rhCEMP1 from the 
rhCEMP1/ACP/PEG are presented in Figure 3B. In the case 
of ACPP1 and ACPP2, containing low content of rhCEMP1, 
an ultimately low burst release on the first day (1.72%±0.07% 
for ACPP1 and 1.86%±0.46% for ACPP2) was observed, fol-
lowed by the continuously sustained release up to 4 weeks. 
For the ACPP5 and ACPP8, the initial burst release on day 1 
was 10.1%±1.5% and 20.4%±2.4%, respectively. These 
results indicated that these ACP/PEG nanoparticles could 
load rhCEMP1 well and release it in a sustained manner.
characterization of electrospun 
multiphasic scaffold
The meshes of electrospun nanofibers showed a porous mor-
phology as they were observed in the SEM images (Figure 4). 
The average diameter of PCL/COL, ACP/PCL/COL, and 
rhCEMP1/ACP/PCL/COL fibers was determined to be 130, 
214, and 204 nm, respectively. Electrospun fibers loaded 
with ACPs demonstrated a rough surface with protuberances 
(Figure 4D and E). Energy dispersive X-ray spectroscopy was 
used for the elemental analysis of the scaffolds. In contrast 
with PCL/COL, the calcium and phosphorus elements were 
observed both in the ACP/PCL/COL and rhCEMP1/ACP/
PCL/COL scaffolds, further indicating the presence of ACP 
in the scaffolds (Figure 4F and I).
The proliferation of PDlcs on the 
scaffolds
At day 1, 3, and 7 after cell seeding, SEM showed that 
PDLCs could attach and grow on the multiphasic scaffolds 
ACP/PCL/COL (Figure 5A–C). The cells adhering to the 
fibers appeared to have rounded or spindle-shaped morphol-
ogy. From Figure 5D–F, it can be seen that the PDLCs can 
not only attach but also spread on the surface of the scaffold. 
? ? ??????????????????????????
????? ?????
?????
?????
Figure 1 Transmission electron micrographs of acPs prepared with or without Peg and rhceMP1.
Notes: (A) acP nanoparticles obtained without the presence of Peg had a needlelike shape. (B) The addition of Peg in acP resulted in a core-shell structure. (C) after 
the incorporation of rhceMP1 into the acP nanoparticles, irregular morphology was observed.
Abbreviations: acP, amorphous calcium phosphate; Peg, poly(ethylene glycol); rhceMP1, recombinant human cementum protein 1.
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Figure 2 FTIr spectra of acPs.
Notes: (A) rhceMP1, (B) acP, (C) acP/Peg, and (D) rhceMP1/acP/Peg. The characteristic vibration peaks of tetrahedral PO
4
3− ions at 590–610 cm-1 and around 
1,000 cm-1 are clearly observed in the FTIr spectrum of acP. The large and strong bands at 2,886 cm-1 are attributed to ch2 stretch and the shoulder at 842 cm
-1 was 
attributed to C–O stretch, confirming the presence of PEG. The characteristic peaks of amide I and amide II of rhCEMP1 are at 1,653 and 1,547 cm-1.
Abbreviations: acP, amorphous calcium phosphate; FTIr, Fourier-transform infrared spectroscopy; Peg, poly(ethylene glycol); rhceMP1, recombinant human cementum 
protein 1.
Cells on rhCEMP1/ACP/PCL/COL exhibited extended 
distended, spread morphology. The PDLCs proliferated 
stably during a prolonged culture period on/within ACP/
PCL/COL scaffold, but rhCEMP1/ACP/PCL/COL tended 
to suppress the growth of cells (Figure 5G).
effect of rhceMP1/acP/Pcl/cOl scaffold 
on cementogenic and/or osteogenic 
differentiation of PDlcs in vitro
The scaffolds were cocultured with PDLCs for 7 days. To 
determine if scaffolds induce osteogenic and/or cementogenic 
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Figure 3 rhCEMP1 EE and release profile.
Notes: (A) The ee was correlated reciprocally with the concentration of rhceMP1 inside acP/Peg. (B) Cumulative release profiles of rhCEMP1 from the rhCEMP1/
ACP/PEG went through a low burst release on the first day, followed by the continuously sustained release up to 4 weeks. The results are presented as means ± standard 
deviation (n=3); *P,0.05.
Abbreviations: acP, amorphous calcium phosphate; acPP1, 1% (w/w) rhceMP1 in acP/Peg; acPP2, 2% (w/w) rhceMP1 in acP/Peg; acPP5, 5% (w/w) rhceMP1 in 
ACP/PEG; ACPP8, 8% (w/w) rhCEMP1 in ACP/PEG; EE, encapsulation efficiency; PEG, poly(ethylene glycol); rhCEMP1, recombinant human cementum protein 1.
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Figure 4 The morphology and elemental composition of scaffolds.
Notes: (A) seM image of Pcl/cOl with interconnected pores; (B) higher magnification SEM image exhibited smooth surface; (C) eDX results suggested no ca and P 
present; (D) acP/Pcl/cOl with a rough surface and a diameter of about 200 nm; (E) higher magnification SEM image shows the surface roughness of the fibers; (F) the 
peaks of ca and P suggested the presence of acP. (G) rhceMP1/acP/Pcl/cOl scaffolds with (H) higher magnification SEM image to show the surface roughness of the 
fibers; and (I) the peaks of ca and P suggested the presence of rhceMP1/acP.
Abbreviations: acP, amorphous calcium phosphate; cOl, type I collagen; eDX, energy-dispersive X-ray spectroscopy; Pcl, poly(ε-caprolactone); rhceMP1, recombinant 
human cementum protein 1; seM, scanning electron microscopy.
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Figure 5 Morphology of PDlcs on scaffolds.
Notes: At days 1, 3, and 7 after cell seeding, SEM showed the PDLCs could attach and grow on the multiphasic scaffolds ACP/PCL/COL. The cells adhering to the fibers 
appeared as rounded or spindle-shaped morphology (A–C). cells on rhceMP1/acP/Pcl/cOl exhibited extended distended, spread morphology (D–F). The PDlcs 
proliferated stably during a prolonged culture period on/within acP/Pcl/cOl scaffold, but rhceMP1/acP/Pcl/cOl tended to suppress the growth of cells (G). seM images 
were taken at 1,000× magnification; *P,0.05.
Abbreviations: acP, amorphous calcium phosphate; cOl, Type I collagen; Pcl, poly(ε-caprolactone); PDlcs, periodontal ligament cell; rhceMP1, recombinant human 
cementum protein 1; seM, scanning electron microscopy.
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differentiation, the expressions of cementogenic mark-
ers (CAP and CEMP1) and osteogenic gene markers 
(osteocalcin – OCN and osteopontin – OPN) were analyzed 
by quantitative PCR (Figure 6). ACP/PCL/COL upregulated 
the expression of CAP and CEMP1 (up to 2- and 20-fold). 
Moreover, it increased OCN and OPN expression signifi-
cantly by 16- and 3-fold, respectively. This indicated that 
ACP/PCL/COL facilitated both osteogenesis and cemento-
genesis. The ability of cementogenesis was intensified for 
rhCEMP1/ACP/PCL/COL compared to ACP/PCL/COL, 
with 44-fold CAP and 5-fold CEMP1 expression. In contrast, 
the expression of OCN was rather limited with rhCEMP1/
ACP/PCL/COL and it was just one-fifth of ACP/PCL/COL. 
Notably, the expression of OPN could not be detected. This 
result proved that rhCEMP1/ACP/PCL/COL had the ability 
to induce cementogenic differentiation of PDLCs. Mean-
while, it controlled osteogenesis; therefore, there would be 
more chances for cementogenesis.
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Figure 6 gene expression by PDlcs seeded on the scaffolds at day 7 of culture.
Notes: acP/Pcl/cOl upregulated the expression of CAP (A) and CEMP1 (B). The ability of cementogenesis was intensified for rhCEMP1/ACP/PCL/COL compared to 
acP/Pcl/cOl. acP/Pcl/cOl increased OCN and OPN expression. In contrast, the expression of OCN was rather limited with rhceMP1/acP/Pcl/cOl (C). Notably, 
the expression of OPN could not be detected (D). Data are mean ± sD (n=3) normalized to β-actin, then relative to control. *P,0.05 versus control; #P,0.05 between 
indicated groups.
Abbreviations: acP, amorphous calcium phosphate; CAP, cementum attachment protein; CEMP1, cementum protein 1; cOl, Type I collagen; OCN, osteocalcin; 
OPN, osteopontin; Pcl, poly(ε-caprolactone); rhceMP1, recombinant human cementum protein 1; sD, standard deviation; Undet, undetected.
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In vivo mineralized tissue regeneration
To investigate the osteoinductive and cementoinductive 
potential of the scaffolds, ACP/PCL/COL and rhCEMP1/
ACP/PCL/COL were implanted orthotopically in the calvaria 
defect of a rat. None of the rats showed evidence of inflamma-
tory or immune response after the implantation. All animals 
used in this experiment were sacrificed at 4 and 8 weeks.
Micro-CT images were examined to determine the degree 
of mineralization along with the distribution of the newly 
formed mineralized tissue. At 4 weeks, the control group 
(untreated defect; Figure 7A) remained open with minimal 
mineralized regions at the center of the defect or on regions 
confined mostly to the defect edges. For defects filled with 
ACP/PCL/COL scaffolds at 4 weeks, moderately mineralized 
regions with uniform bone growth were observed (Figure 7B). 
The edges of the regenerated calvarial defect appeared to be 
continuous with the surrounding bone in the control group, 
while bone regeneration was distributed through the ACP/
PCL/COL scaffold surface layer by layer. The defects filled 
with rhCEMP1/ACP/PCL/COL had a much higher density 
(Figure 7C). At 8 weeks, defects in control and ACP/PCL/
COL displayed almost complete closure (Figure 7D and E). 
However, the defects in rhCEMP1/ACP/PCL/COL remained 
open with some mineralized regions characterized by non-
uniform low-density shadows (Figure 7F). The bone density 
of control and ACP/PCL/COL was quite similar at both 
4 and 8 weeks. Mineralization took place, and bone density 
was doubled at 8 weeks. In contrast, the bone density in 
rhCEMP1/ACP/PCL/COL was a little higher than the other 
groups at 4 weeks. However, it stopped increasing and ended 
up with a lower density at 8 weeks (Figure 7G).
Histological sections stained with H&E for calvaria defect 
treated with control, ACP/PCL/COL, and rhCEMP1/ACP/
PCL/COL scaffolds at 4 and 8 weeks after the implanta-
tion of the scaffolds are shown in Figure 8. At 4 weeks, 
margins of the defect were connected by a thin connective 
fibrous tissue in the control, but no evidence of bone forma-
tion was observed (Figure 8A). For the defect treated with 
ACP/PCL/COL scaffold, it was almost filled with a layer of 
bonelike tissue (Figure 8B). Island-like new bone was dis-
tributed discretely in rhCEMP1/ACP/PCL/COL (Figure 8C). 
Further analysis at higher magnification using sections 
stained with H&E staining and Masson’s trichrome stain-
ing exhibited abundant vascularization in ACP/PCL/COL 
(Figure 8H). A layer of regular cementum-like cells stained 
in purple was seen surrounding the rhCEMP1/ACP/PCL/
COL. Adjacent to the targeted light purple cementum-like 
cells was a layer of ligament tissue. The outermost space was 
occupied by new bone (Figure 8I). The purple, light blue, 
and dark blue stained tissues constituted a sandwich structure 
resembling the periodontal complex. In Masson’s trichrome 
staining, the sandwich structure was distinctly recognized, 
as the cementum-like layer was pink and purple, whereas 
the ligament layer and bone layer were light blue and dark 
blue, respectively (Figure 8O). At 8 weeks, similar tissue 
accumulated, except for new bone formation in the control 
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Figure 7 evaluation of mineralization in calvarial defect via micro-cT showing mineralized bone formation at 4 and 8 weeks postimplantation of the scaffolds.
Notes: at 4 weeks, (A–C) the control group remained open while in acP/Pcl/cOl and rhceMP1/acP/Pcl/cOl scaffolds moderately mineralized regions with uniform 
bone growth were observed. at 8 weeks, (D–E) defects in control and acP/Pcl/cOl displayed almost complete closure. (F) The defects in rhceMP1/acP/Pcl/cOl 
remained open with some mineralized regions characterized by nonuniform low-density shadows. (G) The bone density in rhceMP1/acP/Pcl/cOl was a little higher than 
the other groups at 4 weeks. however, it ceased increasing and ended up with a lower density at 8 weeks. *P,0.05.
Abbreviations: acP, amorphous calcium phosphate; ceMP1, cementum protein 1; cOl, type I collagen; cT, computed tomography; Pcl, poly(ε-caprolactone); rhceMP1, 
recombinant human cementum protein 1.
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Figure 8 h&e histological staining and Masson’s trichrome staining for samples from rat calvaria defect model after 4 and 8 weeks postimplantation.
Notes: (A and G) Control-4 weeks: margins of the defect are connected by a thin dense connective fibrous tissue; (B and H) acP/Pcl/cOl-4 weeks: the defect is 
almost filled with bonelike tissue with vessels on the surface of the scaffold; (C) rhceMP1/acP/Pcl/cOl-4 weeks: there is not much new bone regenerating but a layer of 
regular cementum-like basophilic cells stained light blue-purple was seen surrounding the scaffold. ligament-like tissue was seen adjacent to the bone-like tissue (I). (D and 
J) control-8 weeks: the bonelike tissue formed showed lamellar features with limited small vessels. (E) acP/Pcl/cOl-8 weeks: similar to (B) with more bone formation, 
abundant neovascularization was seen in (K). (F) rhceMP1/acP/Pcl/cOl-8 weeks: the defect has a closure of about 60% by bonelike tissue. cementum-like tissue has an 
increment (L). Masson’s trichrome staining (M–R). all microphotographs were taken at 400× magnification.
Abbreviations: acP, amorphous calcium phosphate; b, bonelike tissue; c, cementum-like tissue; cOl, type I collagen; h&e, hematoxylin and eosin; l, ligamentlike tissue; 
Pcl, poly(ε-caprolactone); rhceMP1, recombinant human cementum protein 1; s, scaffold; V, vessel.
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(Figure 8D). Nonetheless, deficient vascularization hindered 
the extension of new bone (Figure 8J). Large amounts of bony 
nodules, both in number and size, were observed in ACP/
PCL/COL, which led to the formation of the strips of bony 
tissue. These bony tissue islands were surrounded by dense 
connective tissue (Figure 8E, K, and Q). The layer of purple 
cementum-like tissue increased to more than 5-fold of the 
amount at 4 weeks. The bony island extended to 40%, lead-
ing to closure of the defect (Figure 8F). Masson’s trichrome 
staining (Figure 8M–R) was similar to H&E (Figure 8G–L) 
staining, in which bonelike tissue, vessel, ligament-like 
tissue, cementum-like tissue were dark blue, red, light blue, 
and blue-purple, respectively.
Discussion
Considering the increasing aging population worldwide, 
there is a major need for the regeneration of periodontal 
tissue for maintaining normal tooth function. The ability to 
regenerate cementum tissue is crucial to this clinical chal-
lenge. We have designed and fabricated a novel multiphase 
scaffold with rhCEMP1, which can be released in a controlled 
manner. It was demonstrated that the rhCEMP1/ACP/PCL/
COL scaffold has the potential of generating cementum-like 
tissue in vitro and in vivo. This may be a novel method to 
use a cementum-specific inductive scaffold for cementum 
regeneration, for which data has so far not been published.
In this study, it was observed that the rhCEMP1/ACP/
PCL/COL scaffold enhanced the cementogenic differentia-
tion of seeded PDLCs in vitro by upregulating the expression 
of typical cementoblastic gene markers CAP and CEMP1 
while controlling the expression of osteoblastic gene markers 
OCN and OPN. Consequently, rhCEMP1/ACP/PCL/COL 
scaffold induced cementum-like tissue formation and hin-
dered bone formation in vivo orthotopically compared to 
ACP/PCL/COL scaffold. These results demonstrate that the 
rhCEMP1 is a key bioactive compound in cementum forma-
tion both in vitro and in vivo.
Stem cells are one of the major players in tissue engi-
neering approaches. The PDL tissue is a key contributor to 
the process of regeneration of the periodontium. It is quite 
complex and composed of several different cell populations, 
including osteoblasts and osteoclasts, cells of the epithelial 
rests of Malassez and cementoblasts. Besides, it also contains 
fibroblasts and undifferentiated mesenchymal stem cells.29 
CEMP1 can induce a cementoblastic phenotype and reduce 
osteoblastic differentiation in PDLCs.30 A large animal 
model demonstrating in situ cementum regeneration must 
be further included in our study. PDL-derived cells would 
have a more favorable effect on PDL formation instead of 
bone marrow mesenchymal stem cells.31 PDLCs served as 
stem cells in in vitro studies. However, the host provides 
the stem cell in in vivo experiments. The most appropriate 
in vivo model to evaluate the ability of CEMP1 to induce 
cementum regeneration would be the tooth root fenestration 
preclinical model.32 This model takes into consideration the 
functional loading of the tooth and should be regarded as an 
in situ cementum regeneration model. However, this model 
requires more sophisticated surgical techniques and longer 
time to treat samples. Therefore, we employed the critical 
size defect model as a preliminary assessment and this model 
could act as an ectopic cementum regeneration model. It is 
noteworthy that both bone and cementum are mineralized 
tissue, which have a higher density performance in micro-CT. 
CEMP1/ACP/PCL/COL exhibited the highest density at 
4 weeks, as the micro-CT data showed. This high-density 
tissue manifested due to enhancement of mineralization and 
this mineralized tissue was proved to be cementum-like tissue 
in H&E sections.
This study shows that cementum regeneration is pos-
sible with a protein-releasing acellular biomaterial scaffold. 
In contrast to cell transplantation, this strategy of endogenous 
regeneration upon controlled releasing of rhCEMP1 offers a 
new approach to the reconstruction of periodontal complex. 
Despite the effective cementum induction, CEMP1 did not 
favor bone regeneration. However, Serrano et al33 reported 
that rhCEMP1 was able to induce 97% regeneration of a 
rat calvaria critical-size defect, with the density and char-
acteristics of the new mineralized tissues being normal for 
bone. This was probably because they applied rhCEMP1 
to a gelatin matrix scaffold, which showed burst release. 
Moreover, gelatin was far more easily degraded, and so it 
was impossible to provide a sustained vehicle for rhCEMP1 
in the 16-week experimental period.34 Alizarin Red S staining 
showed PDLCs cultured in osteogenic induction medium 
increased mineralization, whereas CEMP1 overexperssion 
completely inhibited the mineralization, which was in accor-
dance with our study result.30
Compared to the reparation of connective tissue and 
bone, the metabolism and reparation of cementum are 
much lower. That is probably why in clinical periodontitis 
treatment we would find that osteogenesis takes a dominant 
position, leading to ankylosed tooth and root absorption. 
Here in our study, rhCEMP1 slowed down the proliferation 
of stem cell growth, resulting in cementogenesis. Then, the 
expression of CAP, which symbolized cementogenesis, had 
increased to about 45 times as much as that of the control. 
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In vitro RT-PCR results showed that ACP/PCL/COL 
scaffold favored both osteogenic and cementogenic markers’ 
expression. Particularly, ACP/PCL/COL upregulated the 
expression of CAP and CEMP1 (up to 2- and 20-fold). This 
seemed to be an inspiring sign. Nevertheless, we could 
hardly determine any cementogenesis apart from the new 
bone and vessels in in vivo experiment. The rhCEMP1/ACP/
PCL/COL scaffold enhanced cementogenic differentiation 
of seeded PDLCs in vitro by upregulating the expression 
of typical cementoblastic gene markers CAP and CEMP1 
while controlling the expression of osteoblastic gene markers 
OCN and OPN. It would be interesting to find out the pos-
sible molecular mechanism of how rhCEMP1 regulates 
cementogenesis. A microarray analysis aiming to assess 
differences in gene expression between cementoblasts and 
osteoblasts identified that the Wnt signaling pathway was 
differentially regulated. The expression of the Wnt inhibitors 
Wnt inhibitory factor 1 and secreted frizzled-related protein 1 
was elevated in cementoblasts compared with osteoblasts.35 
Wnt signaling pathway is closely related to the regulation 
of cementogenesis.36,37 On the contrary, downregulation of 
Wnt causes root resorption.38
Regarding the necessity of restoring cementum, peri-
odontal ligament, and alveolar bone, which constitute the 
whole periodontal complex, a combination of more than one 
cytokine such as BMP2 for bone induction39 and bFGF for 
periodontal ligament40 is essential. However, more studies 
are needed to determine the most appropriate combination 
of double or triple cytokines. In addition, attention must be 
paid to the spatiotemporal delivery by modifying the delivery 
system on the basis of cell reaction in vitro.
Conclusion
In this study, we employed ACP as a sustainable delivery 
for rhCEMP1 in vivo. The release profile of the rhCEMP1/
ACP nanoparticles was studied. Then, an electrospun mul-
tiphasic scaffold composed of rhCEMP1/ACP, PCL, and 
COL was fabricated and cocultured with PDLCs to assess 
the biocompatibility and inductivity. Finally, a critical size 
defect rat model was introduced to evaluate the effect of tis-
sue regeneration of the scaffolds. The scaffold showed the 
ability to suppress cell proliferation behavior and upregulate 
the expression of cementoblastic markers while restricting 
the expression of osteoblastic markers when cocultured 
with human PDLCs in vitro for 7 days. Histology analysis 
after implantation in rats for 8 weeks showed that there was 
cementum-like tissue formation, but less bone formation. 
These results indicated the potential of using electrospun 
multiphasic scaffolds for controlled release of rhCEMP1 for 
promoting cementum regeneration in reconstruction of the 
periodontal complex.
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